Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

819
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
819
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

7.3K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

4.2K
4.2K
Tumor Progression02:07

Tumor Progression

7.8K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.8K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "The current situation of intensive care units in Chinese mainland: A nationwide survey" [Journal of Intensive Medicine volume 2 (2026) 132-140].

Journal of intensive medicine·2026
Same author

Video-Based Training on Physicians' Proficiency in Invasive Fungal Disease: A Multicentre, Cluster Randomised Controlled Trial.

Mycoses·2026
Same author

Corrigendum to "Seeing Artery and VEin Simultaneously in the long axis (SAVES) for ultrasound-guided infraclavicular axillary/subclavian vein cannulation: A retrospective analysis" [Journal of Intensive Medicine volume 4 (2025) 350-358.].

Journal of intensive medicine·2026
Same author

Practice guideline on the prevention and treatment of central line-associated bloodstream infection: Part 2 - Treatment.

Journal of intensive medicine·2026
Same author

The current situation of intensive care units in Chinese mainland: A nationwide survey.

Journal of intensive medicine·2026
Same author

Practice guideline on the prevention and treatment of central line-associated bloodstream infection: Part 1--Diagnosis and prevention.

Journal of intensive medicine·2026
Same journal

Starmate: A Lightweight AI Assistant for Autism Caregivers Developed and Evaluated Through a User-Centered Mixed-Methods Framework.

Journal of medical systems·2026
Same journal

Predicting the Predictor: Unresolved Validity Threats in LLM-Based ASA Classification.

Journal of medical systems·2026
Same journal

Development and Internal Validation of a Vectorcardiography-Augmented Model for 12-Month Major Adverse Cardiovascular Events in Chronic Heart Failure.

Journal of medical systems·2026
Same journal

Development and Validation of an Automated Acute Kidney Injury E-Alert System Integrated with Clinical Decision Support for Hospitalized Patients.

Journal of medical systems·2026
Same journal

Calibration of Self-Reported Confidence and Accuracy of Large Language Models in Medical Question Answering.

Journal of medical systems·2026
Same journal

Throughput Benchmarking and Throughput Variance Analysis to Evaluate the Efficiency of an Outpatient Endoscopy Unit.

Journal of medical systems·2026
See all related articles

Related Experiment Video

Updated: Mar 21, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

998

An Algorithm for Creating Prognostic Systems for Cancer.

Dechang Chen1, Huan Wang2, Li Sheng3

  • 1Department of Preventive Medicine and Biostatistics, The Uniformed Services University of the Health Sciences, Bethesda, MD, 20814, USA. dechang.chen@usuhs.edu.

Journal of Medical Systems
|May 19, 2016
PubMed
Summary
This summary is machine-generated.

This study introduces a new cancer classification method using a hierarchical clustering algorithm to incorporate multiple prognostic factors beyond the standard TNM system. This approach aims to improve cancer staging and patient care by analyzing survival outcomes more comprehensively.

Keywords:
Area between curvesBreast cancerDendrogramHierarchical clusteringPrognostic systemSurvivalTNM

More Related Videos

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

845
Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

3.0K

Related Experiment Videos

Last Updated: Mar 21, 2026

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

998
Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

845
Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

3.0K

Area of Science:

  • Oncology
  • Biostatistics
  • Data Science

Background:

  • The TNM staging system, while standard, has limitations due to its reliance on only three factors.
  • Accurate cancer classification is crucial for effective patient care and treatment planning.
  • There is a need for more sophisticated methods to integrate additional prognostic variables.

Purpose of the Study:

  • To propose a novel hierarchical clustering algorithm for developing advanced cancer prognostic systems.
  • To enhance cancer classification by incorporating multiple prognostic factors beyond traditional staging.
  • To improve patient stratification and outcomes prediction through data-driven clustering.

Main Methods:

  • Development of a hierarchical clustering algorithm to group patients based on multiple prognostic factors.
  • Utilizing the area between survival curves to quantify dissimilarity between prognostic factor combinations.
  • Defining prognostic systems by analyzing dendrograms and individual group survival curves.

Main Results:

  • The algorithm successfully clusters combinations of prognostic factors.
  • Survival outcomes are used to define distinct prognostic groups.
  • Demonstration of the algorithm using breast cancer patient data from the SEER Program.

Conclusions:

  • The proposed algorithm offers a flexible framework for augmenting existing cancer staging systems.
  • Incorporating multiple prognostic factors can lead to more accurate cancer classification and personalized patient care.
  • This data-driven approach has significant potential for advancing cancer prognostication.